article · JCO Global Oncology

Health-Related Quality of Life and Financial Burden in Ethiopian Patients With Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitors: A Cross-Sectional Study

Fisihatsion Tadesse
Getahun Asres
Marta Cipriani
Alfonso Piciocchi
Lalise Gemechu
Amha Gebremedhin
Abdulaziz Abubeker
Atalay Mulu Fentie
Francesco Sparano
Daniela Krepper
Fabio Efficace

20242 citationsOpen accessAddis Ababa University

Abstract

Our results indicate that the HRQoL profile of patients with CML living in Ethiopia may be worse across several important functional and symptom domains than that of their peers living in an HIC. In addition, FT is highly prevalent among these patients and it is associated with poorer HRQoL outcomes.

Research topics

Chronic Myeloid Leukemia Treatments
Economic and Financial Impacts of Cancer
Acute Lymphoblastic Leukemia research

Sustainable Development Goals

No Poverty

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1200/go-24-00281

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.